Items where Author is "El-Jawhari, JJ"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 13.

Journal article

BURSKA, A.N., EL-JAWHARI, J.J., WU, J., WAKEFIELD, R.J., MARZO-ORTEGA, H., CONAGHAN, P.G., EMERY, P., PONCHEL, F. and FREESTON, J.E., 2021. Receptor activator of nuclear factor kappa-Β ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis. Clinical and Experimental Rheumatology, 39 (3), pp. 456-462. ISSN 0392-856X

EL-JAWHARI, J.J., GANGULY, P., JONES, E. and GIANNOUDIS, P.V., 2021. Bone marrow multipotent mesenchymal stromal cells as autologous therapy for osteonecrosis: effects of age and underlying causes. Bioengineering, 8 (5): 69. ISSN 2306-5354

PONCHEL, F., CHURCHMAN, S.M., EL-JAWHARI, J.J., BURSKA, A.N., CHAMBERS, P., VITAL, E.M., EL-SHERBINY, Y.M., JONES, E., CONAGHAN, P.G., GOEB, V. and EMERY, P., 2021. Interleukin-7: a potential factor supporting B-cell maturation in the rheumatoid arthritis synovium. Clinical and Experimental Rheumatology, 39 (2), pp. 253-262. ISSN 0392-856X

EL-JAWHARI, J.J., EL-SHERBINY, Y., MCGONAGLE, D. and JONES, E., 2021. Multipotent mesenchymal stromal cells in rheumatoid arthritis and systemic lupus erythematosus; from a leading role in pathogenesis to potential therapeutic saviors? Frontiers in Immunology, 12: 643170. ISSN 1664-3224

JONES, W.G., EL-JAWHARI, J.J., BROCKETT, C.L., KORIA, L., KTISTAKIS, I. and JONES, E., 2021. Multipotential stromal cells in the talus and distal tibia in ankle osteoarthritis – presence, potency and relationships to subchondral bone changes. Journal of Cellular and Molecular Medicine, 25 (1), pp. 259-271. ISSN 1582-1838

GANGULY, P., BURSKA, A., DAVIS, C., EL-JAWHARI, J.J., GIANNOUDIS, P.V. and JONES, E., 2020. Intrinsic type 1 interferon (IFN1) profile of uncultured human bone marrow CD45lowCD271+ multipotential stromal cells (BM-MSCs): the impact of donor age, culture expansion and IFNα and IFNβ stimulation. Biomedicines, 8 (7): 214. ISSN 2227-9059

EL-JAWHARI, J.J., KLEFTOURIS, G., EL-SHERBINY, Y., SALEEB, H., WEST, R.M., JONES, E. and GIANNOUDIS, P.V., 2019. Defective proliferation and osteogenic potential with altered immunoregulatory phenotype of native bone marrow-multipotential stromal cells in atrophic fracture non-union. Scientific Reports, 9 (1): 17340. ISSN 2045-2322

SANJURJO-RODRIGUEZ, C., BABOOLAL, T.G., BURSKA, A.N., PONCHEL, F., EL-JAWHARI, J.J., PANDIT, H., MCGONAGLE, D. and JONES, E., 2019. Gene expression and functional comparison between multipotential stromal cells from lateral and medial condyles of knee osteoarthritis patients. Scientific Reports, 9 (1): 9321.

EL-JAWHARI, J.J., GANGULY, P., CHURCHMAN, S., JONES, E. and GIANNOUDIS, P.V., 2019. The biological fitness of bone progenitor cells in Reamer/Irrigator/Aspirator waste. The Journal of Bone and Joint Surgery, 101 (23), pp. 2111-2119. ISSN 0021-9355

EL-SHERBINY, Y.M., EL-JAWHARI, J.J., MOSELEY, T.A., MCGONAGLE, D. and JONES, E., 2018. T cell immunomodulation by clinically used allogeneic human cancellous bone fragments: a potential novel immunotherapy tool. Scientific Reports, 8: 13535. ISSN 2045-2322

EL-ZAYADI, A.A., JONES, E.A., CHURCHMAN, S.M., BABOOLAL, T.G., CUTHBERT, R.J., EL-JAWHARI, J.J., BADAWY, A.M., ALASE, A.A., EL-SHERBINY, Y.M. and MCGONAGLE, D., 2017. Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathies. Rheumatology, 56 (3), pp. 488-493. ISSN 1462-0324

EL-JAWHARI, J.J., CUTHBERT, R., MCGONAGLE, D., JONES, E. and GIANNOUDIS, P.V., 2017. The CD45low CD271high cell prevalence in bone marrow samples may provide a useful measurement of the bone marrow quality for cartilage and bone regenerative therapy. The Journal of Bone and Joint Surgery, 99 (15), pp. 1305-1313. ISSN 0021-9355

EL-JAWHARI, J.J., EL-SHERBINY, Y.M., SCOTT, G.B., MORGAN, R.S., PRESTWICH, R., BOWLES, P.A., BLAIR, G.E., TANAKA, T., RABBITTS, T.H., MEADE, J.L. and COOK, G.P., 2014. Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes. Molecular Immunology, 58 (2), pp. 160-168. ISSN 0161-5890

This list was generated on Tue Oct 19 20:37:29 2021 UTC.